These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 10599717

  • 1. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW, Wang ST, Liu RT, Chien WY, Tung SC, Lu YC, Chen HY, Lee CH.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [Abstract] [Full Text] [Related]

  • 2. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [Abstract] [Full Text] [Related]

  • 3. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
    Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
    [Abstract] [Full Text] [Related]

  • 4. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [Abstract] [Full Text] [Related]

  • 5. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [Abstract] [Full Text] [Related]

  • 6. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Golger A, Fridman TR, Eski S, Witterick IJ, Freeman JL, Walfish PG.
    J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
    [Abstract] [Full Text] [Related]

  • 7. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
    Kamel N, Güllü S, Dağci Ilgin S, Corapçioğlu D, Tonyukuk Cesur V, Uysal AR, Başkal N, Erdoğan G.
    Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
    [Abstract] [Full Text] [Related]

  • 8. Follow-up of differentiated thyroid carcinoma.
    Pagano L, Klain M, Pulcrano M, Angellotti G, Pasano F, Salvatore M, Lombardi G, Biondi B.
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G.
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [Abstract] [Full Text] [Related]

  • 10. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
    Rosário PW, Borges MA, Fagundes TA, Franco AC, Purisch S.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):121-5. PubMed ID: 15670185
    [Abstract] [Full Text] [Related]

  • 11. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW, Mineiro Filho AF, Lacerda RX, dos Santos DA, Calsolari MR.
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [Abstract] [Full Text] [Related]

  • 12. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 13. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E, Giani C, Agate L, Biagini A, Pieruzzi L, Bianchi F, Brozzi F, Ceccarelli C, Viola D, Piaggi P, Vitti P, Pacini F, Elisei R.
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [Abstract] [Full Text] [Related]

  • 14. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
    Pacini F, Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
    [Abstract] [Full Text] [Related]

  • 15. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH, Chen JF, Yang BY, Liu RT, Tung SC, Chien WY, Lu YC, Kuo MC, Hsieh CJ, Wang PW.
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [Abstract] [Full Text] [Related]

  • 17. Value of repeat stimulated thyroglobulin testing in patients with differentiated thyroid carcinoma considered to be free of disease in the first year after ablation.
    Rosario PW, Furtado MS, Mineiro Filho AF, Lacerda RX, Calsolari MR.
    Thyroid; 2012 May; 22(5):482-6. PubMed ID: 22175271
    [Abstract] [Full Text] [Related]

  • 18. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL, Kloos RT.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.
    Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V.
    J Clin Endocrinol Metab; 2007 Jan; 92(1):82-7. PubMed ID: 17077133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.